Celon Pharma S.A. (WSE:CLN)

Poland · Delayed Price · Currency is PLN

20.65

-0.25 (-1.20%)

Jul 24, 2026, 5:00 PM CET

Celon Pharma Financials Overview

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	-	-	-	-	-	102.25
Revenue Growth	-	-	-	-	-	-11.04%
Gross Profit	-	-	-	-	-	64.26
Operating Income	-24.87	-24.87	-36.81	-10.45	-3.67	6.9
Net Income	-79.36	-79.36	-34.45	-11.61	-0.92	11.94
Earnings Per Share	-1.49	-1.49	-0.65	-0.25	-0.02	-0.24
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Generic medicines	210.72	206.25	176.62	164.39	161.92	169.56
Innovative	46.15	38.09	27.44	49.53	31.97	26.53
Total	256.87	244.34	204.05	213.92	193.89	196.09

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	19.91	19.91	75.09	114.54	164.62	227.55
Total Debt	18.94	18.94	16.93	25.59	26.82	14.92
Net Cash (Debt)	0.97	0.97	58.16	88.95	137.8	212.63
Net Cash Growth	-98.91%	-98.34%	-34.62%	-35.45%	-35.19%	1048.75%
Net Cash Per Share	0.02	0.02	1.08	1.74	2.70	4.55

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Cash Flow	43.36	43.36	-23.75	43.95	70.9	-5.05
Capital Expenditures	-54.44	-54.44	-22.79	-41.35	99.16	64.95
Free Cash Flow	-11.08	-11.08	-46.54	2.6	170.07	59.9
Free Cash Flow Growth	-	-	-	-98.47%	183.91%	-37.41%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Gross Margin	-	-	-	-	-	62.85%
Operating Margin	-	-	-	-	-	6.75%
Pretax Margin	-	-	-	-	-	7.64%
Profit Margin	-	-	-	-	-	11.67%
FCF Margin	-	-	-	-	-	58.58%

Dividends

Fiscal Year	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Dividend Per Share	-	0.290	0.070	0.080
Dividend Per Share Growth	-	314.29%	-12.50%	-66.67%
Dividend Yield	0.29%	0.20%	-0.20%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	337.01	24.15	35.84	72.92	72.92	72.92
P/FCF Ratio	-	-	-	-	-	650.25